22/8/96
We are investigating the molecular basis of congenital nephrotic syndrome. Specifically, we are testing the possibility that mutations of the Wilms tumor (WT1) gene are responsible for at least a subset of diffuse mesangial sclerosis. Ethical approval has been obtained for this project.We require DNA, blood, or post-mortem tissue from patients with DMS.
Many thanks
Dr. Ania Koziell